Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies

Get started →

Sign up to stay up to date with the stocks you care about

Most recent public disclosures: AI-powered summaries of the latest corporate filings

11226

1

Montrose Environmental Group, Inc. Montrose Environmental Group Reports 6.4% Revenue Growth, Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11227

1

Gossamer Bio, Inc. Gossamer Bio Reports Significant Revenue Growth and Improved Operating Performance in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11228

1

Permian Resources Corp Permian Resources Corporation Reports 60% Revenue Growth and Significant Net Income Increase in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11229

1

PROVIDENT FINANCIAL HOLDINGS INC Provident Financial Holdings Reports 8% Net Income Growth, Strong Loan Origination in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11230

1

HAIN CELESTIAL GROUP INC The Hain Celestial Group Reports Decline in Net Sales and Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11231

1

Spyre Therapeutics, Inc. Spyre Therapeutics Reports Financial Results for Q3 2024, Net Loss of $69M

Via official filing (AI summary) | 7 months ago | 0 comments

11232

1

Cadrenal Therapeutics, Inc. Cadrenal Therapeutics Reports Significant Financial Decline in Q3 2024, Net Loss Increases

Via official filing (AI summary) | 7 months ago | 0 comments

11233

1

Vor Biopharma Inc. Vor Biopharma Reports Improved Financials, Advances Clinical Programs, and Faces Nasdaq Compliance Challenge

Via official filing (AI summary) | 7 months ago | 0 comments

11234

1

YUM BRANDS INC Yum! Brands Reports Mixed Q3 2024 Results with 7% Revenue Growth, Net Income Decline

Via official filing (AI summary) | 7 months ago | 0 comments

11235

1

RESEARCH FRONTIERS INC Research Frontiers Reports 94% Revenue Growth, Improved Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11236

1

LIGHTPATH TECHNOLOGIES INC LightPath Technologies Reports 4% Revenue Growth, Net Loss in Q1 FY2025

Via official filing (AI summary) | 7 months ago | 0 comments

11237

1

Carter Bankshares, Inc. Carter Bankshares Reports Mixed Q3 Results, Net Income Up 55% Year-Over-Year

Via official filing (AI summary) | 7 months ago | 0 comments

11238

1

FIRST FINANCIAL BANCORP /OH/ First Financial Bancorp Reports Mixed Q3 2024 Results, Assets and Loans Grow Amid Profitability Challenges

Via official filing (AI summary) | 7 months ago | 0 comments

11239

1

Cars.com Inc. Cars.com Reports Mixed Q3 Results with Revenue Growth, Decreased Operating Income

Via official filing (AI summary) | 7 months ago | 0 comments

11240

1

INTERNATIONAL BANCSHARES CORP International Bancshares Corporation Reports 5.5% Asset Growth, 3.4% Net Income Decline in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11241

1

Tecnoglass Inc. Tecnoglass Reports Strong Q3 and 9M 2024 Financials with Revenue and Profit Growth

Via official filing (AI summary) | 7 months ago | 0 comments

11242

1

OnKure Therapeutics, Inc. Reneo Pharmaceuticals Reports Financial Changes Following Merger with Legacy OnKure

Via official filing (AI summary) | 7 months ago | 0 comments

11243

1

Wheeler Real Estate Investment Trust, Inc. Wheeler REIT Reports Mixed Q3 Results, Net Loss, and Increased Cash and Cash Equivalents

Via official filing (AI summary) | 7 months ago | 0 comments

11244

1

SIMMONS FIRST NATIONAL CORP Simmons First National Corporation Reports Mixed Q3 Results, Decline in Profitability Amid Increased Credit Risk

Via official filing (AI summary) | 7 months ago | 0 comments

11245

1

Vera Therapeutics, Inc. Vera Therapeutics Reports Significant Financial Developments, Increased Losses Amid Clinical Trial Spending

Via official filing (AI summary) | 7 months ago | 0 comments

11246

1

Janover Inc. Janover Inc. Reports 6% Revenue Growth, Mixed Financial Results for Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11247

1

Bluejay Diagnostics, Inc. Bluejay Diagnostics Reports Improved Financials, Reduced Losses, and Advancements in Symphony Technology Platform

Via official filing (AI summary) | 7 months ago | 0 comments

11248

1

PINNACLE FINANCIAL PARTNERS INC Pinnacle Financial Partners Reports Strong Q3 Earnings, Asset Growth, and Increased Loan Portfolio

Via official filing (AI summary) | 7 months ago | 0 comments

11249

1

CBIZ, Inc. CBIZ Reports 6.9% Revenue Growth, Decline in Operating Income in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments

11250

1

Cardiff Oncology, Inc. Cardiff Oncology Reports Decline in Assets, Increase in Liabilities, and Net Loss in Q3 2024

Via official filing (AI summary) | 7 months ago | 0 comments